The history of chromosomal instability in genome doubled tumors.


Journal

Cancer discovery
ISSN: 2159-8290
Titre abrégé: Cancer Discov
Pays: United States
ID NLM: 101561693

Informations de publication

Date de publication:
01 Jul 2024
Historique:
accepted: 27 06 2024
received: 25 10 2023
revised: 22 04 2024
medline: 29 6 2024
pubmed: 29 6 2024
entrez: 29 6 2024
Statut: aheadofprint

Résumé

Tumors frequently display high chromosomal instability and contain multiple copies of genomic regions. Here, we describe GRITIC, a generic method for timing genomic gains leading to complex copy number states, using single-sample bulk whole-genome sequencing data. By applying GRITIC to 6,091 tumors, we found that non-parsimonious evolution is frequent in the formation of complex copy number states in genome-doubled tumors. We measured chromosomal instability before and after genome duplication in human tumors and found that late genome doubling was followed by an increase in the rate of copy number gain. Copy number gains often accumulate as punctuated bursts, commonly after genome doubling. We infer that genome duplications typically affect the landscape of copy number losses, while only minimally impacting copy number gains. In summary, GRITIC is a novel copy number gain timing framework that permits the analysis of copy number evolution in chromosomally unstable tumors.

Identifiants

pubmed: 38943574
pii: 746202
doi: 10.1158/2159-8290.CD-23-1249
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Toby M Baker (TM)

The Francis Crick Institute, United Kingdom.

Siqi Lai (S)

The University of Texas MD Anderson Cancer Center, Houston, Texas, United States.

Andrew R Lynch (AR)

The University of Texas MD Anderson Cancer Center, United States.

Tom Lesluyes (T)

The Francis Crick Institute, London, United Kingdom.

Haixi Yan (H)

The Francis Crick Institute, United Kingdom.

Huw A Ogilvie (HA)

The University of Texas MD Anderson Cancer Center, Houston, Texas, United States.

Annelien Verfaillie (A)

The Francis Crick Institute, London, United Kingdom.

Stefan Dentro (S)

DKFZ-ZMBH Alliance, Germany.

Amy L Bowes (AL)

The Francis Crick Institute, United Kingdom.

Nischalan Pillay (N)

University College London, London, United Kingdom.

Adrienne M Flanagan (AM)

University College London, London, United Kingdom.

Charles Swanton (C)

The Francis Crick Institute, London, United Kingdom.

Paul T Spellman (PT)

Oregon Health & Science University, Portland, OR, United States.

Maxime Tarabichi (M)

Université Libre de Bruxelles, Anderlecht, Brussels, Belgium.

Peter Van Loo (P)

The University of Texas MD Anderson Cancer Center, Houston, Texas, United States.

Classifications MeSH